CN115894624B - A method for detecting gold nanoclusters and chlortetracycline hydrochloride using polypeptides as ligands - Google Patents
A method for detecting gold nanoclusters and chlortetracycline hydrochloride using polypeptides as ligands Download PDFInfo
- Publication number
- CN115894624B CN115894624B CN202211715289.6A CN202211715289A CN115894624B CN 115894624 B CN115894624 B CN 115894624B CN 202211715289 A CN202211715289 A CN 202211715289A CN 115894624 B CN115894624 B CN 115894624B
- Authority
- CN
- China
- Prior art keywords
- detection
- polypeptides
- gold nanoclusters
- chlortetracycline hydrochloride
- ligands
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 87
- OGQYJDHTHFAPRN-UHFFFAOYSA-N 2-fluoro-6-(trifluoromethyl)benzonitrile Chemical compound FC1=CC=CC(C(F)(F)F)=C1C#N OGQYJDHTHFAPRN-UHFFFAOYSA-N 0.000 title claims abstract description 50
- 229960003185 chlortetracycline hydrochloride Drugs 0.000 title claims abstract description 50
- 102000004196 processed proteins & peptides Human genes 0.000 title claims abstract description 43
- 229920001184 polypeptide Polymers 0.000 title claims abstract description 40
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 title claims abstract description 39
- 239000010931 gold Substances 0.000 title claims abstract description 39
- 229910052737 gold Inorganic materials 0.000 title claims abstract description 39
- 239000003446 ligand Substances 0.000 title claims abstract description 24
- 238000000034 method Methods 0.000 title claims abstract description 20
- 238000001514 detection method Methods 0.000 claims abstract description 59
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 21
- 239000007788 liquid Substances 0.000 claims abstract description 7
- 239000002253 acid Substances 0.000 claims description 10
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 9
- 238000006243 chemical reaction Methods 0.000 claims description 8
- 238000002360 preparation method Methods 0.000 claims description 6
- 230000008859 change Effects 0.000 claims description 2
- 230000001225 therapeutic effect Effects 0.000 claims 2
- 239000002105 nanoparticle Substances 0.000 claims 1
- 238000002474 experimental method Methods 0.000 abstract description 5
- 238000011084 recovery Methods 0.000 abstract description 3
- 230000035945 sensitivity Effects 0.000 abstract description 3
- 239000000243 solution Substances 0.000 description 35
- CYDMQBQPVICBEU-UHFFFAOYSA-N chlorotetracycline Natural products C1=CC(Cl)=C2C(O)(C)C3CC4C(N(C)C)C(O)=C(C(N)=O)C(=O)C4(O)C(O)=C3C(=O)C2=C1O CYDMQBQPVICBEU-UHFFFAOYSA-N 0.000 description 25
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 21
- 239000011347 resin Substances 0.000 description 21
- 229920005989 resin Polymers 0.000 description 21
- 229940024606 amino acid Drugs 0.000 description 17
- 235000001014 amino acid Nutrition 0.000 description 17
- 150000001413 amino acids Chemical class 0.000 description 17
- 238000010647 peptide synthesis reaction Methods 0.000 description 17
- 101150113720 aunc gene Proteins 0.000 description 13
- 125000003088 (fluoren-9-ylmethoxy)carbonyl group Chemical group 0.000 description 11
- 239000003153 chemical reaction reagent Substances 0.000 description 10
- 238000010586 diagram Methods 0.000 description 10
- 230000000694 effects Effects 0.000 description 9
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 8
- 238000010511 deprotection reaction Methods 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 7
- 238000003786 synthesis reaction Methods 0.000 description 7
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- 238000004108 freeze drying Methods 0.000 description 6
- 239000000843 powder Substances 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- FEMOMIGRRWSMCU-UHFFFAOYSA-N ninhydrin Chemical compound C1=CC=C2C(=O)C(O)(O)C(=O)C2=C1 FEMOMIGRRWSMCU-UHFFFAOYSA-N 0.000 description 4
- 238000012546 transfer Methods 0.000 description 4
- GSNUFIFRDBKVIE-UHFFFAOYSA-N DMF Natural products CC1=CC=C(C)O1 GSNUFIFRDBKVIE-UHFFFAOYSA-N 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 239000003242 anti bacterial agent Substances 0.000 description 3
- 229940088710 antibiotic agent Drugs 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 239000012535 impurity Substances 0.000 description 3
- 230000035484 reaction time Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 230000002452 interceptive effect Effects 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 125000006239 protecting group Chemical group 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000004007 reversed phase HPLC Methods 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 229940072172 tetracycline antibiotic Drugs 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 238000003828 vacuum filtration Methods 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- SGKRLCUYIXIAHR-AKNGSSGZSA-N (4s,4ar,5s,5ar,6r,12ar)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide Chemical compound C1=CC=C2[C@H](C)[C@@H]([C@H](O)[C@@H]3[C@](C(O)=C(C(N)=O)C(=O)[C@H]3N(C)C)(O)C3=O)C3=C(O)C2=C1O SGKRLCUYIXIAHR-AKNGSSGZSA-N 0.000 description 1
- YEDUAINPPJYDJZ-UHFFFAOYSA-N 2-hydroxybenzothiazole Chemical compound C1=CC=C2SC(O)=NC2=C1 YEDUAINPPJYDJZ-UHFFFAOYSA-N 0.000 description 1
- GSDSWSVVBLHKDQ-UHFFFAOYSA-N 9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid Chemical compound FC1=CC(C(C(C(O)=O)=C2)=O)=C3N2C(C)COC3=C1N1CCN(C)CC1 GSDSWSVVBLHKDQ-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 101100204059 Caenorhabditis elegans trap-2 gene Proteins 0.000 description 1
- 241001609213 Carassius carassius Species 0.000 description 1
- 241000238424 Crustacea Species 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 241000252212 Danio rerio Species 0.000 description 1
- 241000238578 Daphnia Species 0.000 description 1
- 241001494246 Daphnia magna Species 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 108010059993 Vancomycin Proteins 0.000 description 1
- 244000144974 aquaculture Species 0.000 description 1
- 238000009360 aquaculture Methods 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 229960003121 arginine Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 238000005251 capillar electrophoresis Methods 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 229960002433 cysteine Drugs 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000003795 desorption Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 229960003722 doxycycline Drugs 0.000 description 1
- 238000000295 emission spectrum Methods 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003517 fume Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 229960002743 glutamine Drugs 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000000589 high-performance liquid chromatography-mass spectrometry Methods 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 229960002885 histidine Drugs 0.000 description 1
- NPZTUJOABDZTLV-UHFFFAOYSA-N hydroxybenzotriazole Substances O=C1C=CC=C2NNN=C12 NPZTUJOABDZTLV-UHFFFAOYSA-N 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- 229960003136 leucine Drugs 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000000520 microinjection Methods 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 239000002086 nanomaterial Substances 0.000 description 1
- 229960001699 ofloxacin Drugs 0.000 description 1
- 229960004368 oxytetracycline hydrochloride Drugs 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 231100000719 pollutant Toxicity 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 229960001153 serine Drugs 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000010532 solid phase synthesis reaction Methods 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 238000001269 time-of-flight mass spectrometry Methods 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- MWKJTNBSKNUMFN-UHFFFAOYSA-N trifluoromethyltrimethylsilane Chemical compound C[Si](C)(C)C(F)(F)F MWKJTNBSKNUMFN-UHFFFAOYSA-N 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- -1 vancomycin Chemical compound 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Abstract
本发明提供一种以多肽为配体的金纳米簇及盐酸金霉素的检测方法,所述的以多肽为配体的金纳米簇中,多肽的序列为CCYFFKGGaa;所述的以多肽为配体的金纳米簇可以应用于盐酸金霉素的检测以及河水或湖水中盐酸金霉素的检测。将本发明制备的以多肽为配体的金纳米簇加入到待测样液中,金纳米簇的终浓度不小于0.25mM;在180rpm的摇床中37‑50℃温度下反应10‑20min后,检测荧光变化,观察420nm及695nm处的荧光强度,对于盐酸金霉素的检测具有特异性;本发明的检测方法检测灵敏度高,抗干扰能力强,检出限低,检测曲线相关系数高,在湖水检测回收实验中重现性好,在盐酸金霉素的检测中具有很好的实用价值。
The invention provides a method for detecting gold nanoclusters with polypeptides as ligands and chlortetracycline hydrochloride. In the gold nanoclusters with polypeptides as ligands, the sequence of the polypeptides is CCYFFKGGaa; the polypeptides are used as ligands. The bulk gold nanoclusters can be applied to the detection of chlortetracycline hydrochloride and the detection of chlortetracycline hydrochloride in river or lake water. The gold nanoclusters with polypeptides as ligands prepared by the present invention are added to the sample liquid to be tested, and the final concentration of the gold nanoclusters is not less than 0.25mM; after reacting for 10-20 minutes in a 180rpm shaker at a temperature of 37-50°C , detect fluorescence changes, observe the fluorescence intensity at 420nm and 695nm, and have specificity for the detection of chlortetracycline hydrochloride; the detection method of the present invention has high detection sensitivity, strong anti-interference ability, low detection limit, and high detection curve correlation coefficient. It has good reproducibility in lake water detection and recovery experiments, and has good practical value in the detection of chlortetracycline hydrochloride.
Description
技术领域Technical field
本发明属于纳米材料领域,涉及一种金纳米簇及其制备方法,特别涉及一种多肽和以多肽为配体制备的金纳米簇及利用该金纳米簇进行盐酸金霉素的检测方法。The invention belongs to the field of nanomaterials and relates to a gold nanocluster and a preparation method thereof. In particular, it relates to a polypeptide and a gold nanocluster prepared with the polypeptide as a ligand and a method for detecting chlortetracycline hydrochloride using the gold nanocluster.
背景技术Background technique
由于抗生素在养殖业和畜牧业中的大量使用,导致其对水环境污染的问题日趋严重,已成为当前国际研究热点之一。目前,关于抗生素对水生生物的毒性研究主要集中在细菌、藻类和甲壳类。四环素类抗生素是养殖业和畜牧业中使用最多、最广泛的一类抗生素。盐酸金霉素属于四环素类抗生素中的一种,对大型溞属于低毒性物质,对斑马鱼和鲫鱼则属于中毒性物质。在自然环境中,溞和鱼组成了水环境中重要的食物链,而污染物通过食物链在高营养级生物体内富集,这对于处在食物链最高等级的人类将构成更大的健康威胁。Due to the extensive use of antibiotics in breeding and animal husbandry, the problem of water environment pollution has become increasingly serious and has become one of the current international research hotspots. At present, research on the toxicity of antibiotics to aquatic organisms mainly focuses on bacteria, algae and crustaceans. Tetracycline antibiotics are the most widely used antibiotics in aquaculture and animal husbandry. Chlortetracycline hydrochloride is one of the tetracycline antibiotics. It is a low-toxic substance to Daphnia magna and a toxic substance to zebrafish and crucian carp. In the natural environment, daphnia and fish form an important food chain in the water environment, and pollutants are accumulated in high-trophic-level organisms through the food chain, which will pose a greater health threat to humans at the highest level of the food chain.
目前盐酸金霉素的检测方法包括高效液相色谱-质谱联用法、酶联免疫吸附测定法、毛细管电泳法、分光光度计检测法、电化学免疫分析法、荧光单峰检测方法等,传统的色谱分析方法需要昂贵的实验设备或复杂的预处理过程,而且检测速度慢,检测灵敏度低;荧光单峰检测方法特异性低,检测结果不稳定,抗干扰能力差。Current detection methods for chlortetracycline hydrochloride include high performance liquid chromatography-mass spectrometry, enzyme-linked immunosorbent assay, capillary electrophoresis, spectrophotometer detection, electrochemical immunoassay, fluorescence single peak detection, etc. Traditional Chromatographic analysis methods require expensive experimental equipment or complex pretreatment processes, and have slow detection speeds and low detection sensitivity; fluorescence single-peak detection methods have low specificity, unstable detection results, and poor anti-interference ability.
发明内容Contents of the invention
为了解决上述技术问题,本发明提供一种多肽,和以此多肽为配体制备的金纳米簇及其应用,应用该金纳米簇进行盐酸金霉素的检测。In order to solve the above technical problems, the present invention provides a polypeptide, a gold nanocluster prepared with the polypeptide as a ligand and its application. The gold nanocluster is used to detect chlortetracycline hydrochloride.
本发明提供一种制备检测盐酸金霉素的金纳米簇的多肽,序列为CCYFFKGGAA。The invention provides a polypeptide for preparing gold nanoclusters for detecting chlortetracycline hydrochloride, and the sequence is CCYFFKGGAA.
本发明提供的一种以多肽为配体制备的金纳米簇,通过以下方法制备:The invention provides a gold nanocluster prepared with a polypeptide as a ligand, which is prepared by the following method:
配制2mM的多肽溶液和2mM的氯金酸溶液;Prepare 2mM peptide solution and 2mM chloroauric acid solution;
AuNCs的合成:向反应容器中加入2mM的多肽溶液和2mM氯金酸溶液,多肽溶液和氯金酸溶液的体积比为1:1;随后立即加入NaOH溶液至pH为14,得到以多肽为配体的金纳米簇。Synthesis of AuNCs: Add 2mM peptide solution and 2mM chloroauric acid solution to the reaction vessel. The volume ratio of the peptide solution and chloroauric acid solution is 1:1; then immediately add NaOH solution to pH 14 to obtain a peptide-based formulation. solid gold nanoclusters.
所述的多肽为模块化策略设计,多肽的序列为CCYFFKGGAA;其中,CCY为金簇稳定还原模块,FFK为功能调控模块。The polypeptide is designed with a modular strategy, and the sequence of the polypeptide is CCYFFKGGAA; among them, CCY is a gold cluster stable reduction module, and FFK is a functional regulation module.
本发明制得的以多肽为配体的金纳米簇应用于盐酸金霉素的检测。The gold nanoclusters with polypeptides as ligands prepared by the present invention are used in the detection of chlortetracycline hydrochloride.
本发明制得的以多肽为配体的金纳米簇应用于河水或湖水中盐酸金霉素的检测。The gold nanoclusters with polypeptides as ligands prepared by the present invention are used for the detection of chlortetracycline hydrochloride in river water or lake water.
本发明提供的一种盐酸金霉素(CTC)的检测方法,包括以下步骤:The invention provides a detection method for chlortetracycline hydrochloride (CTC), which includes the following steps:
将本发明制备的以多肽为配体的金纳米簇加入到待测样液中,金纳米簇的终浓度不小于0.25mM;在180rpm的摇床中37-50℃温度下反应10-20min后,检测荧光变化,观察420nm及695nm处的荧光强度。The gold nanoclusters with polypeptides as ligands prepared in the present invention are added to the sample liquid to be tested, and the final concentration of the gold nanoclusters is not less than 0.25mM; after reacting for 10-20 minutes in a shaker at 180 rpm at a temperature of 37-50°C , detect fluorescence changes and observe the fluorescence intensity at 420nm and 695nm.
本发明的有益效果:Beneficial effects of the present invention:
本发明采用模块化策略设计合成多肽序列,并以多肽为配体制备金纳米簇,利用金纳米簇的荧光性质变化及发射光谱的偏移性质,结合荧光双峰的比值与盐酸金霉素浓度的关系,实现盐酸金霉素的定量分析检测。The present invention adopts a modular strategy to design and synthesize polypeptide sequences, and uses polypeptides as ligands to prepare gold nanoclusters. It utilizes the changes in fluorescence properties of gold nanoclusters and the offset properties of emission spectra, and combines the ratio of fluorescence double peaks with the concentration of chlortetracycline hydrochloride. relationship to achieve quantitative analysis and detection of chlortetracycline hydrochloride.
本发明提供的盐酸金霉素的检测方法具有检测盐酸金霉素的特异性,与传统色谱分析方法相比,不需要昂贵的实验设备,具有简便快速的优点;与传统荧光单峰检测方法相比,双峰检测方法特异性更高,检测结果更加稳定;两种荧光强度之间的自校准效应可以通过这种方式有效地消除检测干扰和背景干扰的波动。此外,本方法检测灵敏度高,抗干扰能力强,检出限低,检测曲线相关系数高,在湖水检测回收实验中重现性好,因此,本方法在盐酸金霉素的检测中具有很好的实用价值。The detection method of chlortetracycline hydrochloride provided by the present invention has the specificity of detecting chlortetracycline hydrochloride. Compared with the traditional chromatographic analysis method, it does not require expensive experimental equipment and has the advantages of simplicity and speed; it is comparable to the traditional fluorescence single peak detection method. Compared with the double-peak detection method, the specificity is higher and the detection results are more stable; the self-calibration effect between the two fluorescence intensities can effectively eliminate the fluctuation of detection interference and background interference in this way. In addition, this method has high detection sensitivity, strong anti-interference ability, low detection limit, high detection curve correlation coefficient, and good reproducibility in lake water detection and recovery experiments. Therefore, this method has good performance in the detection of chlortetracycline hydrochloride. practical value.
附图说明Description of the drawings
图1为本发明以多肽为配体的金纳米簇的荧光性质示意图;Figure 1 is a schematic diagram of the fluorescence properties of gold nanoclusters using polypeptides as ligands according to the present invention;
图2为本发明检测方法中金纳米簇不同浓度荧光强度示意图一;Figure 2 is a schematic diagram of the fluorescence intensity of different concentrations of gold nanoclusters in the detection method of the present invention;
图3为本发明检测方法中金纳米簇不同浓度荧光强度示意图二;Figure 3 is a schematic diagram 2 of the fluorescence intensity of different concentrations of gold nanoclusters in the detection method of the present invention;
图4为本发明检测方法中不同反应温度荧光强度示意图一;Figure 4 is a schematic diagram of fluorescence intensity at different reaction temperatures in the detection method of the present invention;
图5为本发明检测方法中不同反应温度荧光强度示意图二;Figure 5 is a schematic diagram 2 of fluorescence intensity at different reaction temperatures in the detection method of the present invention;
图6为本发明检测方法中不同反应时间荧光强度示意图;Figure 6 is a schematic diagram of fluorescence intensity at different reaction times in the detection method of the present invention;
图7为本发明不同的CTC检测浓度荧光强度示意图;Figure 7 is a schematic diagram of fluorescence intensity at different CTC detection concentrations according to the present invention;
图8为本发明检测方法的线性关系示意图;Figure 8 is a schematic diagram of the linear relationship of the detection method of the present invention;
图9为本发明不同干扰离子对检测效果的荧光强度影响示意图;Figure 9 is a schematic diagram of the influence of different interfering ions on the fluorescence intensity of the detection effect according to the present invention;
图10为本发明不同干扰物质对检测效果的荧光强度影响示意图。Figure 10 is a schematic diagram of the influence of different interfering substances on the fluorescence intensity of the detection effect of the present invention.
具体实施方式Detailed ways
本实施例提供一种制备检测盐酸金霉素的金纳米簇的多肽,序列为CCYFFKGGAA。This embodiment provides a polypeptide for preparing gold nanoclusters for detecting chlortetracycline hydrochloride, with the sequence CCYFFKGGAA.
本实施例提供的一种以多肽为配体制备的金纳米簇,通过以下方法制备:This example provides a gold nanocluster prepared with a polypeptide as a ligand, prepared by the following method:
多肽的合成:Synthesis of peptides:
使用固相合成法合成多肽,所述的多肽为模块化策略设计,多肽的序列为CCYFFKGGAA。具体实施方法如下:The polypeptide was synthesized using a solid-phase synthesis method. The polypeptide was designed with a modular strategy. The sequence of the polypeptide is CCYFFKGGAA. The specific implementation methods are as follows:
(1)树脂的浸泡活化(1) Soaking activation of resin
将树脂加入到多肽合成管中,沿管壁四周加入10mL的二氯甲烷(DCM),将合成管密封后置于实验室通风橱中浸泡过夜,使树脂完全活化。Add the resin into the peptide synthesis tube, add 10 mL of dichloromethane (DCM) around the tube wall, seal the synthesis tube and place it in a laboratory fume hood to soak overnight to fully activate the resin.
(2)树脂的Fmoc保护基团脱保护(2) Deprotection of the Fmoc protecting group of the resin
树脂浸泡过夜后,将多肽合成管中的DCM溶液去除,加入Fmoc基团脱保护试剂将多肽合成管倾斜放置于25℃的恒温摇床中,匀速摇晃30min后取出,将多肽合成管中的脱保护试剂去除。按先后顺序分别加入约6mL的DCM、异丙醇和DMF到多肽合成管中,每种试剂浸泡2分钟,之后用真空泵减压抽滤去除试剂,保证树脂能够被充分洗涤。After the resin is soaked overnight, remove the DCM solution from the peptide synthesis tube, add the Fmoc group deprotection reagent, place the peptide synthesis tube at an angle in a constant temperature shaker at 25°C, shake at a constant speed for 30 minutes, take it out, and remove the deprotection reagent from the peptide synthesis tube. Protection reagent removal. Add approximately 6 mL of DCM, isopropanol, and DMF to the peptide synthesis tube in order, soak each reagent for 2 minutes, and then use a vacuum pump to remove the reagents by vacuum filtration to ensure that the resin can be fully washed.
(3)茚三酮法检测树脂的Fmoc基团脱保护(3) Ninhydrin method to detect the deprotection of the Fmoc group of the resin
从合成管中取出微量树脂转移至0.15mL的离心管中,并向其中加入溶液A和溶液B,100℃恒温加热5min后取出,若离心管中树脂全部呈蓝紫色,则证明树脂上的Fmoc基团完全脱保护。溶液A为溶于无水乙醇的水和茚三酮,溶液B为溶于无水乙醇的熔融苯酚,下同。Take a trace amount of resin from the synthesis tube and transfer it to a 0.15mL centrifuge tube, add solution A and solution B to it, heat at a constant temperature of 100°C for 5 minutes and then take it out. If all the resin in the centrifuge tube turns blue-purple, it proves that Fmoc on the resin The group is completely deprotected. Solution A is water and ninhydrin dissolved in absolute ethanol, and solution B is molten phenol dissolved in absolute ethanol, the same below.
(4)Fmoc基团保护的氨基酸活化(4) Activation of amino acids protected by Fmoc group
根据需要连接的氨基酸的分子量,称量出1.2mmol Fmoc基团保护的氨基酸置于10mL的离心管中,向其中依次加入2.4mL的HBTU,2.4mL的HOBT和330μL的DIEA,并用漩涡振荡器震荡EP管促进氨基酸的溶解,静置10min使其完全活化。According to the molecular weight of the amino acid to be connected, weigh out 1.2 mmol of the Fmoc group-protected amino acid and place it in a 10 mL centrifuge tube. Add 2.4 mL of HBTU, 2.4 mL of HOBT and 330 μL of DIEA to it in sequence, and shake with a vortex oscillator. The EP tube promotes the dissolution of amino acids and leaves it for 10 minutes to fully activate.
(5)氨基酸的连接(5)Connection of amino acids
首先将完全活化的氨基酸加入到含有树脂的多肽合成管中,然后再加入12mL的DCM,最后加入3mL的二甲苯使树脂完全悬浮。将多肽合成管倾斜放置于25℃的恒温摇床中,匀速摇晃3.5h后取出,用真空泵减压抽滤将多肽合成管中的溶液去除。按先后顺序加入约6mL的DMF、异丙醇和DCM到多肽合成管中,之后用真空泵减压抽滤去除试剂,每种试剂重复加入两次,每次浸泡2min,保证树脂能够被充分洗涤。First, add fully activated amino acids to the peptide synthesis tube containing the resin, then add 12 mL of DCM, and finally add 3 mL of xylene to completely suspend the resin. Place the peptide synthesis tube at an angle in a constant-temperature shaker at 25°C, shake at a constant speed for 3.5 hours, take it out, and use a vacuum pump to filter under reduced pressure to remove the solution in the peptide synthesis tube. Add about 6 mL of DMF, isopropyl alcohol and DCM to the peptide synthesis tube in sequence, and then use a vacuum pump to remove the reagents by vacuum filtration. Each reagent is added twice and soaked for 2 minutes each time to ensure that the resin can be fully washed.
(6)茚三酮法检测氨基酸的连接(6) Ninhydrin method to detect the connection of amino acids
从合成管中取出微量树脂转移至0.15mL的离心管中,分别加入溶液A和溶液B,100℃恒温加热5min后取出,若离心管中树脂全部呈透亮黄色,则证明此氨基酸完全连接,可以进行下一个氨基酸的连接;若有一部分树脂呈淡蓝色,则说明此氨基酸没有完全连接,需要重复步骤(4)-(6),对此氨基酸进行重新连接。Take out a small amount of resin from the synthesis tube and transfer it to a 0.15mL centrifuge tube. Add solution A and solution B respectively, heat at a constant temperature of 100°C for 5 minutes and then take it out. If all the resin in the centrifuge tube turns bright yellow, it proves that the amino acids are completely connected. Connect the next amino acid; if part of the resin turns light blue, it means that the amino acid is not completely connected, and you need to repeat steps (4)-(6) to reconnect the amino acid.
(7)氨基酸的Fmoc保护基团脱保护(7) Deprotection of Fmoc protecting group of amino acids
向多肽合成管中加入16mL的Fmoc基团脱保护试剂,将多肽合成管倾斜放置于25℃的恒温摇床中,匀速摇晃30min后取出,去除脱保护试剂。按先后顺序依次加入约6mL的DCM、异丙醇和DMF对树脂进行洗涤,每种试剂重复加入两次,每次浸泡2min。Add 16 mL of Fmoc group deprotection reagent to the peptide synthesis tube, place the peptide synthesis tube at an angle in a constant temperature shaker at 25°C, shake at a constant speed for 30 minutes, then take it out and remove the deprotection reagent. Add about 6 mL of DCM, isopropyl alcohol and DMF in order to wash the resin. Repeat each reagent added twice and soak for 2 minutes each time.
(8)茚三酮法检测氨基酸的Fmoc基团脱保护(8) Ninhydrin method to detect deprotection of Fmoc group of amino acids
从合成管中取出微量树脂转移至0.15mL的离心管中,并向其中加入溶液A和溶液B各50μL,100℃恒温加热5min后取出,若离心管中树脂全部呈蓝紫色,则证明树脂上的Fmoc基团完全脱保护;若有一部分树脂呈透亮黄色,则说明此氨基酸的Fmoc基团没有完全脱保护,则需要对其重新脱保护。Take out a small amount of resin from the synthesis tube and transfer it to a 0.15mL centrifuge tube, add 50 μL each of solution A and solution B, heat at 100°C for 5 minutes and then take it out. If all the resin in the centrifuge tube turns blue-purple, it means that the resin has The Fmoc group of the amino acid is completely deprotected; if part of the resin is bright yellow, it means that the Fmoc group of the amino acid is not completely deprotected, and it needs to be deprotected again.
重复步骤(4)-(8),进行下一个氨基酸的连接,氨基酸按照从右向左的顺序连接。Repeat steps (4)-(8) to connect the next amino acid, and the amino acids are connected in order from right to left.
多肽的剪切:Cleavage of polypeptides:
(1)向经过抽真空干燥后的多肽合成管中加入剪切液:三氟乙酸,TIS,超纯水,共计20mL。(1) Add shear liquid: trifluoroacetic acid, TIS, and ultrapure water to the vacuum-dried peptide synthesis tube, totaling 20 mL.
(2)将多肽合成管倾斜放置于25℃恒温摇床中,匀速摇晃2h后取出,将多肽合成管安装到事先准备好的装有预冷无水乙醚的抽滤瓶上,让剪切液缓慢流入到抽滤瓶中,直到多肽合成管中没有液体留出后,将装有粗肽析出的抽滤瓶取下封口置于-20℃冰箱中保存。(2) Place the peptide synthesis tube in a 25°C constant-temperature shaker at an angle, shake it at a constant speed for 2 hours, and then take it out. Install the peptide synthesis tube into a prepared filter bottle filled with pre-cooled anhydrous ether and let the shear liquid Slowly flow into the filtration flask until no liquid remains in the peptide synthesis tube. Remove the seal from the filtration flask containing the crude peptide and store it in a -20°C refrigerator.
(3)再次向多肽合成管中加入上述剪切液的一半用量,将多肽合成管倾斜放置于25℃的恒温摇床中,匀速摇晃1h后取出,重复步骤(2)。(3) Add half the amount of the above-mentioned shear solution to the peptide synthesis tube again, place the peptide synthesis tube at an angle in a constant temperature shaker at 25°C, shake at a constant speed for 1 hour, take it out, and repeat step (2).
(4)静置大约2-3h直至所有多肽从预冷的无水乙醚中析出,用G4漏斗过滤除去无水乙醚,随后用药匙将粗肽从G4漏斗上刮下来,也可用50%的乙腈/水冲洗漏斗,然后用适量的50%的乙腈/水溶解粗肽于冻干瓶中。(4) Let it stand for about 2-3 hours until all the peptides precipitate from the pre-cooled anhydrous ether. Use a G4 funnel to filter to remove the anhydrous ether. Then use a spoon to scrape the crude peptide off the G4 funnel. You can also use 50% acetonitrile. /water to rinse the funnel, and then use an appropriate amount of 50% acetonitrile/water to dissolve the crude peptide in the freeze-drying bottle.
(5)提前2h将冷阱打开预冷,将冻干瓶放置在低温冷阱槽中旋转,使多肽溶液旋冻成冰,直至所有的多肽溶液均匀的挂在冻干瓶内壁上,然后采用冷冻干燥的方法利用冷冻干燥机将粗肽冻干完全,最终形成粗肽粉末,将粗肽称量记录后置于-20℃冰箱中保存备用。(5) Open the cold trap 2 hours in advance to pre-cool, place the freeze-drying bottle in the low-temperature cold trap tank and rotate it to spin-freeze the peptide solution into ice until all the peptide solution hangs evenly on the inner wall of the freeze-drying bottle, and then use The freeze-drying method uses a freeze dryer to freeze-dry the crude peptide completely, and finally forms crude peptide powder. The crude peptide is weighed and recorded and then stored in a -20°C refrigerator for later use.
多肽的纯化:Purification of peptides:
(1)粗肽样品预处理(1) Crude peptide sample pretreatment
用4mL离心管称量20mg左右粗肽粉末,加入4mL去离子水,置于漩涡振荡器上震荡,使粗肽粉末充分溶解到水中,溶解后的多肽需要用0.22μm孔径的有机滤膜过滤去除杂质。Weigh about 20 mg of crude peptide powder in a 4 mL centrifuge tube, add 4 mL of deionized water, and shake on a vortex oscillator to fully dissolve the crude peptide powder into the water. The dissolved peptide needs to be filtered out with an organic filter membrane with a pore size of 0.22 μm. Impurities.
(2)粗肽分析(2) Crude peptide analysis
采用岛津LC-20A半制备型反向高效液相色谱对粗肽样品进行分析,设定粗肽分析程序,用微量进样针吸取15μL经过滤的粗肽样品,色谱图中信号最强的峰一般为目的多肽的出峰时间,根据粗肽样品的出峰时间可以进一步优化粗肽分析程序以及设定合适的多肽制备程序。Use Shimadzu LC-20A semi-preparative reverse-phase high-performance liquid chromatography to analyze the crude peptide sample. Set the crude peptide analysis program and use a micro-injection needle to draw 15 μL of the filtered crude peptide sample. The signal in the chromatogram is the strongest. The peak is generally the peak elution time of the target peptide. Based on the peak elution time of the crude peptide sample, the crude peptide analysis program can be further optimized and the appropriate peptide preparation program can be set.
(3)多肽制备(3) Peptide preparation
采用岛津LC-20A半制备型反向高效液相色谱对粗肽样品进行小量制备,打开设定好的多肽样品制备程序,用5mL进样针吸取4mL经过滤的粗肽样品注入到泵中后制备程序自动执行,同时打开样品自动收集器,自动收集制备出来的流动相。根据多肽制备的色谱图,确定目的多肽的出峰时间,从而找出对应的管再次进行多肽分析,和之前进行的粗肽分析的出峰时间相比较,若出峰时间一致且没有其他杂峰,则证明该管为所要的目的多肽。确定所有含有目的多肽且无其他杂质的收集管并转移至冻干瓶中,置于低温冷阱槽中旋转成冰,然后利用冷冻干燥机将纯肽冻干成纯肽粉末,称量记录后置于-20℃冰箱中保存备用。Use Shimadzu LC-20A semi-preparative reverse-phase high-performance liquid chromatography to prepare crude peptide samples in small quantities. Open the set peptide sample preparation program, use a 5mL syringe to draw 4mL of filtered crude peptide sample and inject it into the pump. The intermediate and post-preparation procedures are automatically executed, and the automatic sample collector is opened at the same time to automatically collect the prepared mobile phase. According to the chromatogram prepared by the peptide, determine the peak time of the target peptide, and then find the corresponding tube and perform peptide analysis again. Compare it with the peak time of the previous crude peptide analysis. If the peak time is consistent and there are no other impurity peaks, , it proves that the tube is the desired target polypeptide. Determine all collection tubes containing the target polypeptide and without other impurities and transfer them to freeze-drying bottles. Place them in a low-temperature cold trap and spin them into ice. Then use a freeze-drying machine to freeze-dry the pure peptide into pure peptide powder. After weighing and recording Store in -20°C refrigerator for later use.
鉴定:Identification:
用基质辅助激光解析串联飞行时间质谱仪进行检测,确定纯肽分子量从而确定制备出的是否为目的多肽。Use matrix-assisted laser desorption tandem time-of-flight mass spectrometry for detection to determine the molecular weight of the pure peptide to determine whether the prepared peptide is the target peptide.
多肽溶液的配制:Preparation of peptide solution:
取一定量的多肽粉末,使用屈臣氏蒸馏水配制成2mM的多肽溶液;Take a certain amount of peptide powder and use Watsons distilled water to prepare a 2mM peptide solution;
氯金酸溶液的配制:Preparation of chloroauric acid solution:
取50mM的氯金酸母液200uL,加入4800uL的屈臣氏蒸馏水配制成2mM的氯金酸溶液;Take 200uL of 50mM chloroauric acid stock solution and add 4800uL of Watson's distilled water to prepare a 2mM chloroauric acid solution;
AuNCs的合成:Synthesis of AuNCs:
取1.5mL EP管,先加入200uL、2mM的多肽溶液,再加入200uL、2mM氯金酸溶液,随后立即加入10uL、2M的NaOH溶液,混匀并使用pH试纸检测混合后的溶液pH为14,得到以多肽为配体的金纳米簇。Take a 1.5mL EP tube, first add 200uL, 2mM peptide solution, then add 200uL, 2mM chloroauric acid solution, then immediately add 10uL, 2M NaOH solution, mix well and use pH test paper to check that the pH of the mixed solution is 14. Gold nanoclusters with polypeptides as ligands were obtained.
本实施例中制备的以多肽为配体的金纳米簇的荧光性质如图1所示,激发波长515nm,发射波长695nm。The fluorescence properties of the gold nanoclusters with polypeptides as ligands prepared in this example are shown in Figure 1, with an excitation wavelength of 515 nm and an emission wavelength of 695 nm.
本实施例将制得的以多肽为配体的金纳米簇应用于盐酸金霉素的检测中,检测方法为:In this example, the prepared gold nanoclusters with polypeptides as ligands are applied to the detection of chlortetracycline hydrochloride. The detection method is:
将本实施例制备的以多肽为配体的金纳米簇加入到待测样液中,金纳米簇的终浓度不小于0.25mM;在180rpm的摇床中37-50℃温度下反应10-20min后,检测荧光变化,观察420nm及695nm处的荧光强度。Add the gold nanoclusters with polypeptides as ligands prepared in this example to the sample liquid to be tested. The final concentration of the gold nanoclusters is not less than 0.25mM; react in a 180rpm shaker at a temperature of 37-50°C for 10-20 minutes. Finally, detect the fluorescence changes and observe the fluorescence intensity at 420nm and 695nm.
效果对比实验:Effect comparison experiment:
根据上述检测方法,分别对比不同反应条件下的检测效果:According to the above detection methods, compare the detection effects under different reaction conditions:
a、AuNCs浓度对比:a. AuNCs concentration comparison:
分别选择AuNCs终浓度为0.05mM(CTC 190uL+AuNCs 10uL)、0.25mM(CTC 150uL+AuNCs 50uL)、0.5mM(CTC 100uL+AuNCs 100uL)、0.75mM(CTC 50uL+AuNCs 150uL)、0.95mM(CTC 10uL+AuNCs 190uL),在180rpm的摇床中37℃下,与终浓度4mM的CTC溶液反应10min,检测荧光变化。如图2-3所示,AuNCs终浓度0.05mM时690nm处的荧光完全消失,所以浓度最小值优选为0.25mM。Select the Auncs final concentration of 0.05mm (CTC 190ul+Auncs 10ul), 0.25mm (CTC 150ul+Auncs 50ul), 0.5mm (CTC 100UL+Auncs 100UL), 0.75mm (CTC 50ul+Auncs 150ul), and 0.95. MM (CTC 10uL + AuNCs 190uL), react with a CTC solution with a final concentration of 4mM for 10min at 37°C in a shaker at 180rpm, and detect the fluorescence change. As shown in Figure 2-3, the fluorescence at 690nm completely disappears when the final concentration of AuNCs is 0.05mM, so the minimum concentration is preferably 0.25mM.
b、反应温度对比:b. Comparison of reaction temperatures:
选择终浓度0.25mM的AuNCs与终浓度4mM的CTC溶液分别在温度4℃、25℃、37℃、50℃条件下于180rpm的摇床中反应10min,检测荧光变化。如图4-5所示,在37℃条件下,荧光强度受温度影响最小,所以温度优选37℃。AuNCs with a final concentration of 0.25mM and CTC solution with a final concentration of 4mM were selected and reacted in a shaker at 180rpm for 10 minutes at temperatures of 4°C, 25°C, 37°C, and 50°C, respectively, and fluorescence changes were detected. As shown in Figure 4-5, under the condition of 37°C, the fluorescence intensity is least affected by temperature, so the temperature is preferably 37°C.
c、反应时间对比:c. Reaction time comparison:
选择终浓度0.25mM的AuNCs与终浓度4mM的CTC溶液在37℃条件下于180rpm的摇床中分别反应10min、20min、30min、40min、50min,检测荧光变化。如图6所示,反应10min时基本达到最终反应结果,所以反应时间至少10min。AuNCs with a final concentration of 0.25mM and CTC solution with a final concentration of 4mM were selected to react in a shaker at 180rpm at 37°C for 10min, 20min, 30min, 40min, and 50min respectively, and the fluorescence changes were detected. As shown in Figure 6, the final reaction result is basically reached after 10 minutes of reaction, so the reaction time is at least 10 minutes.
CTC的检测效果及检出限:CTC detection effect and detection limit:
分别配制CTC终浓度为8、4、2、1、0.5、0.25、0.125、0uM的溶液,取CTC溶液150uL加入50uL AuNCs,混合后放入37℃、180rpm的摇床中反应10min,检测370nm激发下的荧光发射。如图7-8所示,加入CTC后AuNCs的荧光发射位置发生变化,在420nm处出现一个新的发射峰,随着CTC浓度的增大,420nm处的发射峰的荧光强度不断增大,并且F420/F695存在线性关系,检出限为10.3nmol。Prepare solutions with final CTC concentrations of 8, 4, 2, 1, 0.5, 0.25, 0.125, and 0uM respectively. Take 150uL of the CTC solution and add 50uL of AuNCs. After mixing, place it in a shaker at 37°C and 180rpm to react for 10 minutes. Detect 370nm excitation. Fluorescence emission below. As shown in Figure 7-8, the fluorescence emission position of AuNCs changes after adding CTC, and a new emission peak appears at 420nm. As the CTC concentration increases, the fluorescence intensity of the emission peak at 420nm continues to increase, and There is a linear relationship between F420/F695, and the detection limit is 10.3nmol.
抗干扰实验:Anti-interference experiment:
a、分别配制2.1mM的CuSO4、MgSO4、MnCl2、NaCl、CaCO3、Ba(OH)2溶液,分别取10uL加入到200uL AuNCs和AuNCs+CTC中检测对荧光强度的影响。如图9所示,分别在AuNCs和AuNCs+CTC溶液中加入CuSO4、MgSO4、MnCl2、NaCl、CaCO3、Ba(OH)2等离子,发现对荧光强度几乎不会产生影响。a. Prepare 2.1mM CuSO 4 , MgSO 4 , MnCl 2 , NaCl, CaCO 3 , and Ba(OH) 2 solutions respectively, and add 10uL to 200uL AuNCs and AuNCs+CTC to detect the effect on fluorescence intensity. As shown in Figure 9, CuSO 4 , MgSO 4 , MnCl 2 , NaCl, CaCO 3 , and Ba(OH) 2 plasma were added to the AuNCs and AuNCs+CTC solutions respectively, and it was found that there was almost no effect on the fluorescence intensity.
b、分别配制0.341mM的CTC、四环素、多西环素、盐酸土霉素、万古霉素、氧氟沙星、精氨酸、丝氨酸、半胱氨酸、亮氨酸、组氨酸、谷氨酸、异亮氨酸、赖氨酸等,按照本发明的检测方法,依次检测荧光变化。如图10所示,选择其他物质按照CTC的检测方法发现除CTC外其他物质都不会产生420nm处的发射峰。b. Prepare 0.341mM CTC, tetracycline, doxycycline, oxytetracycline hydrochloride, vancomycin, ofloxacin, arginine, serine, cysteine, leucine, histidine, and glutamine respectively. Acid, isoleucine, lysine, etc., according to the detection method of the present invention, the fluorescence changes are detected sequentially. As shown in Figure 10, by selecting other substances and following the CTC detection method, it was found that no other substances except CTC would produce an emission peak at 420 nm.
回收实验:Recycling experiment:
验证本发明检测方法在实际样品中的检测效果,选择湖水,将湖水以10000rpm5min的方法进行离心,离心过后的样品过0.22uM的滤膜,向其中加入CTC,配制成1uM、2uM、3uM的CTC溶液,利用本发明的检测方法检测样品中的CTC的检出浓度。To verify the detection effect of the detection method of the present invention in actual samples, select lake water, centrifuge the lake water at 10,000 rpm for 5 minutes, pass the centrifuged sample through a 0.22uM filter membrane, add CTC to it, and prepare 1uM, 2uM, and 3uM CTC solution, and use the detection method of the present invention to detect the detection concentration of CTC in the sample.
如下表所示,本发明构建的线性模型线性范围为0-8nmol/mL,标准曲线方程为y=0.448x+0.184(y为420nm处的荧光强度与695nm处的荧光强度的比值,x为CTC浓度),相关系数R2=0.999,检测限计算低至10.3nmol,方法得到的回收率为96.8%-103.6%。本发明的检测方法具有良好的检测准确性,对于监测湖水中CTC的残留问题具有重要作用。As shown in the table below, the linear range of the linear model constructed by the present invention is 0-8nmol/mL, and the standard curve equation is y=0.448x+0.184 (y is the ratio of the fluorescence intensity at 420nm to the fluorescence intensity at 695nm, x is CTC concentration), the correlation coefficient R 2 =0.999, the detection limit was calculated as low as 10.3 nmol, and the recovery rate obtained by the method was 96.8%-103.6%. The detection method of the present invention has good detection accuracy and plays an important role in monitoring the residual problem of CTC in lake water.
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211715289.6A CN115894624B (en) | 2022-12-29 | 2022-12-29 | A method for detecting gold nanoclusters and chlortetracycline hydrochloride using polypeptides as ligands |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211715289.6A CN115894624B (en) | 2022-12-29 | 2022-12-29 | A method for detecting gold nanoclusters and chlortetracycline hydrochloride using polypeptides as ligands |
Publications (2)
Publication Number | Publication Date |
---|---|
CN115894624A CN115894624A (en) | 2023-04-04 |
CN115894624B true CN115894624B (en) | 2023-12-08 |
Family
ID=86483928
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211715289.6A Active CN115894624B (en) | 2022-12-29 | 2022-12-29 | A method for detecting gold nanoclusters and chlortetracycline hydrochloride using polypeptides as ligands |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115894624B (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113376130A (en) * | 2021-05-14 | 2021-09-10 | 南京师范大学 | Fluorescence open-type probe for detecting ampicillin residue and preparation method and application thereof |
CN113390843A (en) * | 2021-06-16 | 2021-09-14 | 南通大学 | Preparation method of casein-gold nanocluster and application of casein-gold nanocluster in aureomycin detection |
CN115452787A (en) * | 2022-09-22 | 2022-12-09 | 山东理工大学 | Method for measuring streptomycin in milk by using fluorescence sensor constructed by silver nanoclusters and gold palladium nanoparticles |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK1987178T3 (en) * | 2006-02-20 | 2015-04-20 | Phylogica Ltd | Process for the construction and screening of peptide structure libraries |
-
2022
- 2022-12-29 CN CN202211715289.6A patent/CN115894624B/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113376130A (en) * | 2021-05-14 | 2021-09-10 | 南京师范大学 | Fluorescence open-type probe for detecting ampicillin residue and preparation method and application thereof |
CN113390843A (en) * | 2021-06-16 | 2021-09-14 | 南通大学 | Preparation method of casein-gold nanocluster and application of casein-gold nanocluster in aureomycin detection |
CN115452787A (en) * | 2022-09-22 | 2022-12-09 | 山东理工大学 | Method for measuring streptomycin in milk by using fluorescence sensor constructed by silver nanoclusters and gold palladium nanoparticles |
Non-Patent Citations (3)
Title |
---|
"Sensitive ratiometric fluorescence probe based on chitosan carbon dots and calcein for Alkaline phosphatase detection and bioimaging in cancer cells";Xiaowei Mu 等;《Anal Chim Acta》;第1188卷;doi: 10.1016/j.aca.2021.339163 * |
"荧光金纳米簇定量检测盐酸金霉素和碱性磷酸酶的研究";姜雪;《万方学术论文》;第1-82页 * |
"金纳米簇的微波合成及其在农药检测中的应用研究";吴敏行;《中国优秀硕士学位论文全文数据库 (工程科技Ⅰ辑)》(第1期);B014-1106 * |
Also Published As
Publication number | Publication date |
---|---|
CN115894624A (en) | 2023-04-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Xiong et al. | Molecularly imprinted on-line solid-phase extraction combined with flow-injection chemiluminescence for the determination of tetracycline | |
CN112225782A (en) | Specific peptides and methods for the determination of structural protein content in COVID-19 vaccines | |
CN106565721B (en) | A kind of fluorescent reagent and its identification application of selection identification lysine and methionine | |
CN102914527B (en) | Method for detecting content of free tryptophan in tryptophan and serum sample | |
CN107936035A (en) | A kind of cysteine-modifying graphene quantum dot GQCY and preparation method are with preparing the application on dopamine luciferase assay reagent | |
CN110426435B (en) | A kind of arginine biosensor based on peptide aptamer and preparation method thereof | |
CN115894624B (en) | A method for detecting gold nanoclusters and chlortetracycline hydrochloride using polypeptides as ligands | |
CN108912134A (en) | A kind of fluorescence probe and preparation method, application of highly sensitive detection cysteine | |
CN103951673B (en) | A kind of reagent and the application in mercaptan detects thereof | |
CN110804087B (en) | A kind of AIE fluorescent compound targeted by integrin αvβ3 and its preparation and application | |
EP4028410A1 (en) | Bioreceptor molecules, the use of bioreceptor molecules, sensors containing electrodes modified with the said bioreceptor molecules and the detection method of sars-cov-2 virus | |
CN103304630A (en) | GPCR active polypeptide in scorpion venom of Buthus martensii Karsch, and extracting separation and application thereof | |
CN103170309A (en) | Ractopamine antibody immunoaffinity chromatographic column and application thereof | |
CN110041311A (en) | A kind of fluorescent probe molecule ML-FP and its preparation method and application | |
Wu et al. | Sensitive determination of dissolved tryptophan in freshwater by alkaline hydrolysis and HPLC | |
CN108822839B (en) | A kind of glucosamine modified nano carbon dots GSCs and its preparation method and its application in the preparation of lysine fluorescence detection reagent | |
CN103308639B (en) | Detection method of content of blue algae toxin beta-methylamino-L-alanine in aquatic products | |
CN108760957B (en) | A kind of enrofloxacin sample pretreatment device and content determination method in aquaculture wastewater | |
Zeng et al. | Simultaneous analysis of AY and amino acids in corn oligopeptides by HPLC-fluorescence detector with OPA/FMOC-Cl pre-column derivatization | |
CN111303865B (en) | Fluorescent probe compound and preparation method and application thereof | |
CN111141856B (en) | HPLC method for simultaneously detecting L-homoserine and free amino acid in fermentation liquor | |
Veselý et al. | Determination of α‐l‐aspartyl‐l‐phenylalanine methylester hydrochloride in soft drinks | |
CN114315784A (en) | A kind of histidine-labeled fluorescent probe and its preparation method and application | |
CN106046115B (en) | A kind of novel polypeptide ligand for modifying quantum dot | |
CN108043365B (en) | Affinity enrichment integral material based on bionic small peptide ligand and preparation and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |